What is Viridian Therapeutics, Inc.'s investment purchases?

Viridian Therapeutics, Inc. (VRDN) reported investment purchases of $91.32M in Q1 2026.

How has Viridian Therapeutics, Inc.'s investment purchases changed year-over-year?

Viridian Therapeutics, Inc.'s investment purchases increased by 28.2% year-over-year, from $71.24M to $91.32M.

What is the long-term trend for Viridian Therapeutics, Inc.'s investment purchases?

Over 3 years (2021 to 2025), Viridian Therapeutics, Inc.'s investment purchases has grown at a 45.4% compound annual growth rate (CAGR), from $188.43M to $579.28M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Viridian Therapeutics, Inc. VRDN Investment Purchases

Investment Purchases at other companies

Vir Biotechnology, Inc.VIR

$158.37M-8.8%

Nektar TherapeuticsNKTR

$452.25M+1,714%

Syndax PharmaceuticalsSNDX

$39.39M+274%

Ultragenyx PharmaceuticalRARE

$131M—

Krystal Biotech, Inc.KRYS

$160.03M+16.1%

Arrowhead ResearchARWR

$924.64M+43.5%

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s investment purchases?: Viridian Therapeutics, Inc. (VRDN) reported investment purchases of $91.32M in Q1 2026.
How has Viridian Therapeutics, Inc.'s investment purchases changed year-over-year?: Viridian Therapeutics, Inc.'s investment purchases increased by 28.2% year-over-year, from $71.24M to $91.32M.
What is the long-term trend for Viridian Therapeutics, Inc.'s investment purchases?: Over 3 years (2021 to 2025), Viridian Therapeutics, Inc.'s investment purchases has grown at a 45.4% compound annual growth rate (CAGR), from $188.43M to $579.28M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.